DNA vaccines against leptospirosis: A literature review.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Vaccine

• Publication date

  2017-10-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2017.08.067PMID 28882437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant system AS01: helping to overcome the challenges of modern vaccines

  2017cited by this paper
• The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes

  2016cited by this paper
• HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost

  2016cited by this paper
• Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.

  2016cited by this paper
• Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine

  2016cited by this paper
• A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant

  2015cited by this paper
• Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge

  2015cited by this paper
• DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis

  2015cited by this paper
• Diagnosis of Leptospirosis: Comparison between Microscopic Agglutination Test, IgM-ELISA and IgM Rapid Immunochromatography Test

  2015cited by this paper
• The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response

  2015cited by this paper
• Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years

  2015cited by this paper
• Comparative subproteome analysis of three representative Leptospira interrogans vaccine strains reveals cross-reactive antigens and novel virulence determinants.

  2015cited by this paper
• Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

  2015cited by this paper
• Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse

  2015cited by this paper
• Evaluation of Cell Binding Activities of Leptospira ECM Adhesins

  2015cited by this paper
• DNA vaccination of poultry: The current status in 2015

  2015cited by this paper
• Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.

  2015cited by this paper
• Leptospirosis in Mexico: Epidemiology and Potential Distribution of Human Cases

  2015cited by this paper
• Prevalence and risk factors for Leptospira exposure in New Zealand veterinarians

  2015cited by this paper
• MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life

  2015cited by this paper
• Host response to leptospira infection.

  2015cited by this paper
• The molecular basis of leptospiral pathogenesis.

  2015cited by this paper
• Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components

  2015cited by this paper
• Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate

  2015cited by this paper
• Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.

  2015cited by this paper
• Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine

  2015cited by this paper
• Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants

  2014cited by this paper
• Strategies and hurdles using DNA vaccines to fish

  2014cited by this paper
• Alum and Squalene-Oil-in-Water Emulsion Enhance the Titer and Avidity of Anti-Aβ Antibodies Induced by Multimeric Protein Antigen (1–11)E2, Preserving the Igg1-Skewed Isotype Distribution

  2014cited by this paper
• Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins.

  2014cited by this paper
• Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives

  2014cited by this paper
• Optimization of the Immunogenicity of a DNA Vaccine Encoding a Bacterial Outer Membrane Lipoprotein

  2014cited by this paper
• Production and Characterization of a Polyclonal Antibody of Anti-rLipL21-IgG against Leptospira for Early Detection of Acute Leptospirosis

  2014cited by this paper
• Leptospiral extracellular matrix adhesins as mediators of pathogen-host interactions.

  2014cited by this paper
• DNA vaccines

  2013cited by this paper
• A Conserved Region of Leptospiral Immunoglobulin-Like A and B Proteins as a DNA Vaccine Elicits a Prophylactic Immune Response against Leptospirosis

  2013cited by this paper
• Leptospiral Outer Membrane Protein LipL41 Is Not Essential for Acute Leptospirosis but Requires a Small Chaperone Protein, Lep, for Stable Expression

  2013cited by this paper
• Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation.

  2013cited by this paper
• Synthetic DNA vaccine strategies against persistent viral infections

  2013cited by this paper
• Mechanisms of Action of Adjuvants

  2013cited by this paper
• LipL32 Is a Subsurface Lipoprotein of Leptospira interrogans: Presentation of New Data and Reevaluation of Previous Studies

  2013cited by this paper
• Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.

  2013cited by this paper
• LipL41, a Hemin Binding Protein from Leptospira santarosai serovar Shermani

  2013cited by this paper
• A Prime-Boost Strategy Using the Novel Vaccine Candidate, LemA, Protects Hamsters against Leptospirosis

  2013cited by this paper
• Mannosylated LigANI Produced in Pichia pastoris Protects Hamsters Against Leptospirosis

  2013cited by this paper
• Key roles of adjuvants in modern vaccines

  2013cited by this paper
• Differential In Vivo Gene Expression of Major Leptospira Proteins in Resistant or Susceptible Animal Models

  2012cited by this paper
• Improving the safety of viral DNA vaccines: development of vectors containing both 5′ and 3′ homologous regulatory sequences from non-viral origin

  2012cited by this paper
• Protection against Lethal Leptospirosis after Vaccination with LipL32 Coupled or Coadministered with the B Subunit of Escherichia coli Heat-Labile Enterotoxin

  2012cited by this paper
• OmpL1 Is an Extracellular Matrix- and Plasminogen-Interacting Protein of Leptospira spp

  2012cited by this paper
• Technologies for enhanced efficacy of DNA vaccines

  2012cited by this paper
• Recombinant vaccines and the development of new vaccine strategies

  2012cited by this paper
• A Leptospira borgpetersenii Serovar Hardjo Vaccine Induces a Th1 Response, Activates NK Cells, and Reduces Renal Colonization

  2011cited by this paper
• Leptospirosis: Aspects of Innate Immunity, Immunopathogenesis and Immune Evasion From the Complement System

  2011cited by this paper
• Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model.

  2011cited by this paper
• The inflammasome: an integrated view

  2011cited by this paper
• Recombinant vaccines against Leptospirosis

  2011cited by this paper
• Characteristic features of intracellular pathogenic Leptospira in infected murine macrophages

  2011cited by this paper
• Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56 Peptide in Incomplete Freund Adjuvant

  2010cited by this paper
• Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant

  2010cited by this paper
• Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

  2010cited by this paper
• Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.

  2010cited by this paper
• Identification of Immunodominant B- and T-Cell Combined Epitopes in Outer Membrane Lipoproteins LipL32 and LipL21 of Leptospira interrogans

  2010cited by this paper
• Cross-Reactivity of Antibodies against Leptospiral Recurrent Uveitis-Associated Proteins A and B (LruA and LruB) with Eye Proteins

  2010cited by this paper
• TLR4- and TLR2-Mediated B Cell Responses Control the Clearance of the Bacterial Pathogen, Leptospira interrogans1

  2009cited by this paper
• Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira.

  2009cited by this paper
• Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

  2009cited by this paper
• IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells

  2009cited by this paper
• DNA Immunization as an Efficient Strategy for Vaccination

  2009cited by this paper
• AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity1

  2009cited by this paper
• Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen

  2009cited by this paper
• Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of Human Immunodeficiency Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation

  2008cited by this paper
• DNA vaccines: ready for prime time?

  2008cited by this paper
• Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.

  2008cited by this paper
• Protection of Guinea Pigs against Leptospira interrogans Serovar Lai by LipL21 DNA Vaccine

  2008cited by this paper
• The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.

  2007cited by this paper
• Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers.

  2007cited by this paper
• Current status of leptospirosis in Japan and Philippines.

  2007cited by this paper
• The OmpA-Like Protein Loa22 Is Essential for Leptospiral Virulence

  2007cited by this paper
• OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. challenge.

  2007cited by this paper
• Physiological Osmotic Induction of Leptospira interrogans Adhesion: LigA and LigB Bind Extracellular Matrix Proteins and Fibrinogen

  2007cited by this paper
• Immunoprotection of Recombinant Leptospiral Immunoglobulin-Like Protein A against Leptospira interrogans Serovar Pomona Infection

  2006cited by this paper
• The use of oil adjuvants in therapeutic vaccines.

  2006cited by this paper
• Characterization of the Outer Membrane Proteome of Leptospira interrogans Expressed during Acute Lethal Infection

  2006cited by this paper
• Surfaceome of Leptospira spp

  2005cited by this paper
• Protection against Leptospira interrogans Sensu Lato Challenge by DNA Immunization with the Gene Encoding Hemolysin-Associated Protein 1

  2005cited by this paper
• Differential TLR Recognition of Leptospiral Lipid A and Lipopolysaccharide in Murine and Human Cells1

  2005cited by this paper
• Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba

  2004cited by this paper
• [Efficacy and safety of a vaccine against human leptospirosis in Cuba].

  2004cited by this paper
• Adjuvants in veterinary vaccines: modes of action and adverse effects.

  2003cited by this paper
• An evaluation of the serological and epidemiological effects of the outer envelope vaccine to leptospira.

  2003cited by this paper
• LipL21 Is a Novel Surface-Exposed Lipoprotein of Pathogenic Leptospira Species

  2003cited by this paper
• Evaluation of Type 1 Immune Response in Naïve and Vaccinated Animals following Challenge with Leptospira borgpetersenii Serovar Hardjo: Involvement of WC1+ γδ and CD4 T Cells

  2002cited by this paper
• Rapid Translocation of Polarized MDCK Cell Monolayers by Leptospira interrogans, an Invasive but Nonintracellular Pathogen

  2002cited by this paper
• Evaluation of type 1 immune response in naïve and vaccinated animals following challenge with Leptospira borgpetersenii serovar Hardjo: involvement of WC1(+) gammadelta and CD4 T cells.

  2002cited by this paper
• Characterization of the Leptospiral Outer Membrane and Description of Three Novel Leptospiral Membrane Proteins

  2002cited by this paper
• Novel 45-Kilodalton Leptospiral Protein That Is Processed to a 31-Kilodalton Growth-Phase-Regulated Peripheral Membrane Protein

  2002cited by this paper
• Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism

  2001cited by this paper
• DNA vaccines.

  1997cited by this paper
• An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle

  1996cited by this paper

• Immunoinformatics design and in vivo evaluation of a multiepitope vaccine targeting OMPL1, Lipl32, Lipl41, and Lipl46 for leptospirosis in a male ICR mouse model.

  2026cites this paper
• Leptospira prevalence and lineages vary across land-use types due to shifts in small mammal communities

  2026cites this paper
• Silent Carriers: The Role of Rodents in the Emergence of Zoonotic Bacterial Threats

  2025cites this paper
• Evaluation of a DNA vector plasmid encoding a partial rop18 gene from toxoplasma gondii in domestic cats as a vaccine candidate.

  2025cites this paper
• Designing a broad-spectrum multi-epitope subunit vaccine against leptospirosis using immunoinformatics and structural approaches

  2025cites this paper
• Recombinant chimeric proteins offer new hope to control of leptospirosis.

  2025cites this paper
• Trends and advances in Leptospira, a bibliometric analysis

  2025cites this paper
• Pathologic Tissue Injury and Inflammation in Mice Immunized with Plasmid DNA-Encapsulated DOTAP-Based Lipid Nanoparticles

  2024cites this paper
• Exploring mucosal vaccination as an alternative to conventional vaccines

  2024cites this paper
• Nanocarrier vaccine therapeutics for global infectious and chronic diseases

  2023cites this paper
• Innovation-driven trend shaping COVID-19 vaccine development in China

  2023cites this paper
• Improvement the expression and purification of Loa22: a lipoprotein with OmpA domain from pathogenic Leptospira serovars

  2023cites this paper
• The Cooperation of IL-29 and PLGA Nanoparticles Improves the Protective Immunity of the gD-1 DNA Vaccine Against Herpes Simplex Virus Type 1 in Mice

  2023cites this paper
• Human leptospirosis: In search for a better vaccine

  2023cites this paper
• Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)

  2023cites this paper
• Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji

  2022cites this paper
• Post-Vaccination Leptospiral Antibody Titers among Pet Dogs in Malaysia

  2022cites this paper
• Revisiting the Development of Vaccines Against Pathogenic Leptospira: Innovative Approaches, Present Challenges, and Future Perspectives

  2022cites this paper
• New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA

  2022cites this paper
• DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model

  2022cites this paper
• Going Micro in Leptospirosis Kidney Disease

  2022cites this paper
• COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries

  2022cites this paper
• Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine

  2022influential citation
• A global overview of the most important zoonotic bacteria pathogens transmitted from Rattus norvegicus to humans in urban environments

  2022cites this paper
• Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

  2022cites this paper
• Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates

  2022cites this paper
• Advanced strategies for development of vaccines against human bacterial pathogens

  2021cites this paper
• Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization

  2021cites this paper
• Effect of COVID-19 on vaccination coverage in Brazil.

  2021cites this paper
• Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans

  2021cites this paper
• Vaccine Development and Immune Responses in COVID-19: Lessons from the Past

  2021cites this paper
• COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies

  2021cites this paper
• mRNA as a Therapeutics: Understanding mRNA Vaccines

  2021cites this paper
• Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice

  2021cites this paper
• Occurrence of Leptospira spp. and factors associated with the infection in horses from a military contingent in the Rio Grande do Sul State, Brazil

  2021cites this paper
• RETRACTED ARTICLE: Expression and preliminary characterization of the potential vaccine candidate LipL32 of leptospirosis

  2021cites this paper
• Mixing of Sputnik V and AstraZeneca COVID-19 vaccines

  2021cites this paper
• Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

  2021cites this paper
• Leptospirosis and Weil’s Syndrome

  2020cites this paper
• Analyzing 16S rRNA sequences from Vietnamese pathogenic Leptospira strains and in-silico prediction of potential antigenic epitopes on LipL21, LipL32 outer membrane lipoproteins

  2020cites this paper
• Investigating the Immunological and Biological Equilibrium of Reservoir Hosts and Pathogenic Leptospira: Balancing the Solution to an Acute Problem?

  2020cites this paper
• Tropical Nephrology

  2020cites this paper
• Vaccine delivery strategies against botulism

  2020cites this paper
• DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection

  2020cites this paper
• Interleukin 34 Serves as a Novel Molecular Adjuvant against Nocardia Seriolae Infection in Largemouth Bass (Micropterus Salmoides)

  2020cites this paper
• Construction of an Effective Delivery System for DNA Vaccines Using Biodegradable Polylactic Acid Based Microspheres.

  2020cites this paper
• DNA vaccines against COVID-19: Perspectives and challenges

  2020cites this paper
• Biopolymer Xanthan: A New Adjuvant for DNA Vaccines

  2020influential citation
• Incidência da Doença Meningocócica no Rio Grande do Sul entre 2014 a 2018

  2020cites this paper
• Current State of the Art in DNA Vaccine Delivery and Molecular Adjuvants: Bcl-xL Anti-Apoptotic Protein as a Molecular Adjuvant

  2019cites this paper
• Vaccines the tugboat for prevention-based animal production

  2019cites this paper
• Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.

  2019cites this paper
• Improvement the Expression and Puri�cation of Loa22: A Lipoprotein with OmpA domain from Pathogenic Leptospira Serovars

  year unknowncites this paper